COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,401 Articles (22,816 medRxiv, 8,585 bioRxiv)

Most recent first Previous |  Page 1513: Articles 15121-15130  | Next

Frailty variation models for susceptibility and exposure to SARS-CoV-2
Gomes, M. G. M., Ferreira, M. U., Chikina, M., Pegden, W., Aguas, R.
10.1101/2021.05.25.21257766 — Posted: 2021-05-26
Effective prophylaxis of COVID-19 in rhesus macaques using a combination of two parentally-administered SARS-CoV-2 neutralizing antibodies
Beddingfield, B. J., Maness, N. J., Fears, A. C., Rappaport, J., Aye, P. P., Russell-Lodrigue, K. E., Doyle-Meyers, L. A., Blair, R. V., Carias, A. M., Redondo, R. L., Madden, P. J., Gao, H., Montefiori, D., Hope, T. J., ROY, C. J.
10.1101/2021.05.26.445878 — Posted: 2021-05-26
Impaired function and delayed regeneration of dendritic cells in COVID-19
Winheim, E., Rinke, L., Lutz, K., Reischer, A., Leutbecher, A., Wolfram, L., Rausch, L., Kranich, J., Wratil, P. R., Huber, J., Baumjohann, D., Rothenfusser, S., Hellmuth, J., Scherer, C., Muenchhoff, M., von Bergwelt-Baildon, M., Stark, K., Straub, T., Brocker, T., Keppler, O. T., Subklewe, M., Krug, A. B.
10.1101/2021.05.26.445809 — Posted: 2021-05-26
Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence
Talla, A., Vasaikar, S. V., Lemos, M. P., Moodie, Z., Pebworth, M.-P. L., Henderson, K. E., Cohen, K. W., Czartoski, J. L., Lai, L., Suthar, M. S., Heubeck, A. T., Genge, P. C., Roll, C. M., Weiss, M., Reading, J., Kondza, N., MacMillan, H., Fong, O. C., Thomson, Z. J., Graybuck, L. T., Newell, E. W., Coffey, E. M., Meijer, P., Becker, L. A., De Rosa, S. C., Torgerson, T. R., Skene, P. J., Li, X., Szeto, G. L., McElrath, M. J., Bumol, T. F.
10.1101/2021.05.26.442666 — Posted: 2021-05-26
Emergence of a new SARS-CoV-2 variant from GR clade with a novel S glycoprotein mutation V1230L in West Bengal, India
Sarkar, R., Saha, R., Mallick, P., Sharma, R., Kaur, A., Dutta, S., Chawla-Sarkar, D. M.
10.1101/2021.05.24.21257705 — Posted: 2021-05-26
Standardised, quantitative neutralisation responses to SARS-CoV-2 Variants of Concern by convalescent anti-sera from first wave infections of UK Health Care Workers and Patients
Cantoni, D., Mayora-Neto, M., Nadesalingam, A., Wells, D. A., Carnell, G. W., Ohlendorf, L., Ferrari, M., Palmer, P., Chan, A., Smith, P., Bentley, E. M., Einhauser, S., Wagner, R., Page, M., Raddi, G., Baxendale, H., Heeney, J., Temperton, N. J., Humoral Immune Correlates for COVID19 Consortium
10.1101/2021.05.24.21257729 — Posted: 2021-05-26
Cohort profile: Actionable Register of Geneva Outpatients with SARS-CoV-2 (ARGOS)
Genecand, C., Koegler, F., Lebowitz, D., Mongin, D., Regard, S., Nehme, M., Braillard, O., Grira, M., Joubert, D., Chopard, P., Delaporte, E., Stirnemann, J., Guessous, I., Tardin, A., Courvoisier, D. S.
10.1101/2021.05.24.21256813 — Posted: 2021-05-26
Possibility of SARS-CoV-2 infection in metastatic microenvironment of cancer
Hayashi, T., Konishi, I.
10.1101/2021.05.24.21257662 — Posted: 2021-05-26
Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study
Antonelli, M., Penfold, R. S., Merino, J., Sudre, C. H., Molteni, E., Berry, S., Canas, L. S., Graham, M. S., Klaser, K., Modat, M., Murray, B., Österdahl, M. F., Cheetham, N. J., Drew, D. A., Nguyen, L. A., Capdeila, J., Hu, C., Selvachandran, S., Polidori, L., May, A., Wolf, J., Chan, A. T., Hammers, A., Duncan, E., Spector, T., Ourselin, S., Steves, C. J.
10.1101/2021.05.24.21257738 — Posted: 2021-05-26 Discussion: Onsite
COVID-19 mass testing: harnessing the power of wastewater epidemiology
Fitzgerald, S. F., Rossi, G., Low, A. S., MacAteer, S. P., O'Keefe, B., Findlay, D., Cameron, G. J., Pollard, P., Singleton, P. T. R., Ponton, G., Singer, A. C., Farkas, K., Jones, D. L., Graham, D. W., Quintela-Baluja, M., Tait-Burkard, C., Gally, D. L., Kao, R. R., Corbishley, A.
10.1101/2021.05.24.21257703 — Posted: 2021-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).